Indian biotech firm Panacea Biotec Ltd has begun production of Russia's Sputnik V vaccine against Covid-19, said the Russian Direct Investment Fund (RDIF), which markets the shot internationally.
The first batch made by the Indian manufacturer will be shipped to Gamaleya, the Moscow institute which developed the vaccine, for quality controls, RDIF said in a statement.
Full-scale production is expected to begin this summer, RDIF added.






























